LB Pharmaceuticals Inc Common Stock (LBRX) Institutional Ownership

Based on Q1 2026 13F filings, institutional ownership of LB Pharmaceuticals Inc Common Stock stands at 80.8%, held across 76 reporting institutions.

Deep Track Capital, LP is the largest reported institutional holder of LBRX, with approximately 3,352,804 shares worth $0.08B as of Q1 2026.

Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of LBRX, including CITADEL ADVISORS LLC.

Our composite Smart Money Score for LBRX is 63 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

20 institutions opened new positions in LBRX during Q1 2026, while 12 fully exited. 47 added to existing positions and 8 trimmed.

LBRX institutional ownership rose by 13.19 percentage points quarter-over-quarter, with a net change of +8 holders.

The top 10 institutions account for 65.2% of all reported 13F value in LBRX, and the top 25 account for 93.4%.

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.